00:17:00 EDT Sun 19 May 2024
Enter Symbol
or Name
USA
CA



Login ID:
Password:
Save
Titan Medical Inc (2)
Symbol TMD
Shares Issued 111,202,690
Close 2022-04-28 C$ 0.57
Market Cap C$ 63,385,533
Recent Sedar Documents

Titan Medical to release Q1 results May 12

2022-04-28 12:59 ET - News Release

Mr. Paul Cataford reports

TITAN MEDICAL TO ISSUE FIRST QUARTER 2022 FINANCIAL RESULTS ON MAY 12, 2022

Titan Medical Inc. plans to issue its first quarter 2022 financial results prior to market opening on Thursday, May 12, 2022. In addition, management will host an investor audio webcast at 8:30 a.m. ET to discuss financial results and business highlights. Speakers will include Paul Cataford, interim president and chief executive officer, and Stephen Lemieux, chief financial officer.

A link to the live audio webcast will be made available on the investor relations section of the company's website. A webcast replay will be archived and accessible on the company's website shortly after conclusion of the live audio webcast.

About Titan Medical Inc.

Titan Medical, a medical device company headquartered in Toronto, Ont., and with operations in Chapel Hill, N.C., is focused on enhancing robotic-assisted surgery (RAS) using innovative technology through a single access point. The Enos single-access RAS system is being developed with an ergonomic focus to provide a surgical experience that imitates real-life movements that surgeons demand. The Enos system includes multiarticulating instruments designed to allow surgeons an increased range of motion in a confined space, with dexterity and the ability to exert the forces necessary to complete common surgical tasks. Titan intends to initially pursue gynecologic surgical indications with the Enos system.

We seek Safe Harbor.

© 2024 Canjex Publishing Ltd. All rights reserved.